Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2022

Open Access 12-01-2022 | Diabetes | Research article

Machine learning models for prediction of co-occurrence of diabetes and cardiovascular diseases: a retrospective cohort study

Authors: Ahmad Shaker Abdalrada, Jemal Abawajy, Tahsien Al-Quraishi, Sheikh Mohammed Shariful Islam

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2022

Login to get access

Abstract

Background

Diabetic mellitus (DM) and cardiovascular diseases (CVD) cause significant healthcare burden globally and often co-exists. Current approaches often fail to identify many people with co-occurrence of DM and CVD, leading to delay in healthcare seeking, increased complications and morbidity. In this paper, we aimed to develop and evaluate a two-stage machine learning (ML) model to predict the co-occurrence of DM and CVD.

Methods

We used the diabetes complications screening research initiative (DiScRi) dataset containing >200 variables from >2000 participants. In the first stage, we used two ML models (logistic regression and Evimp functions) implemented in multivariate adaptive regression splines model to infer the significant common risk factors for DM and CVD and applied the correlation matrix to reduce redundancy. In the second stage, we used classification and regression algorithm to develop our model. We evaluated the prediction models using prediction accuracy, sensitivity and specificity as performance metrics.

Results

Common risk factors for DM and CVD co-occurrence was family history of the diseases, gender, deep breathing heart rate change, lying to standing blood pressure change, HbA1c, HDL and TC\HDL ratio. The predictive model showed that the participants with HbA1c >6.45 and TC\HDL ratio > 5.5 were at risk of developing both diseases (97.9% probability). In contrast, participants with HbA1c >6.45 and TC\HDL ratio ≤ 5.5 were more likely to have only DM (84.5% probability) and those with HbA1c ≤5.45 and HDL >1.45 were likely to be healthy (82.4%. probability). Further, participants with HbA1c ≤5.45 and HDL <1.45 were at risk of only CVD (100% probability). The predictive accuracy of the ML model to detect co-occurrence of DM and CVD is 94.09%, sensitivity 93.5%, and specificity 95.8%.

Conclusions

Our ML model can significantly predict with high accuracy the co-occurrence of DM and CVD in people attending a screening program. This might help in early detection of patients with DM and CVD who could benefit from preventive treatment and reduce future healthcare burden.
Literature
1.
go back to reference Islam SMS, et al. Non-communicable diseases (NCDs) in developing countries: a symposium report. Glob Health. 2014;10(1):1–8.CrossRef Islam SMS, et al. Non-communicable diseases (NCDs) in developing countries: a symposium report. Glob Health. 2014;10(1):1–8.CrossRef
2.
go back to reference Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.CrossRef Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
3.
go back to reference International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.
4.
go back to reference Roth GA, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef Roth GA, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef
6.
go back to reference Al-Zubayer MA, Ahammed B, Sarder MA, Kundu S, Majumder UK, Islam SMS. Double and triple burden of non-communicable diseases and its determinants among adults in Bangladesh: Evidence from a recent demographic and health survey. Int J Clin Pract. 2021;7575:e14613. https://doi.org/10.1111/ijcp.14613 Al-Zubayer MA, Ahammed B, Sarder MA, Kundu S, Majumder UK, Islam SMS. Double and triple burden of non-communicable diseases and its determinants among adults in Bangladesh: Evidence from a recent demographic and health survey. Int J Clin Pract. 2021;7575:e14613. https://​doi.​org/​10.​1111/​ijcp.​14613
7.
go back to reference Islam SMS, et al. Prevalence of risk factors for hypertension: a cross-sectional study in an urban area of Bangladesh. Global cardiology science and practice. 2015;2015(4):43.PubMedPubMedCentralCrossRef Islam SMS, et al. Prevalence of risk factors for hypertension: a cross-sectional study in an urban area of Bangladesh. Global cardiology science and practice. 2015;2015(4):43.PubMedPubMedCentralCrossRef
8.
go back to reference Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246.PubMedPubMedCentralCrossRef Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246.PubMedPubMedCentralCrossRef
9.
go back to reference Islam SMS, et al. Cardiovascular diseases risk prediction in patients with diabetes: Posthoc analysis from a matched case-control study in Bangladesh. J Diabetes Metabol Disord. 2021;20(1):417–25.CrossRef Islam SMS, et al. Cardiovascular diseases risk prediction in patients with diabetes: Posthoc analysis from a matched case-control study in Bangladesh. J Diabetes Metabol Disord. 2021;20(1):417–25.CrossRef
10.
go back to reference Collaboration ERF. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRef Collaboration ERF. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRef
12.
go back to reference Islam, S. M. S., Ferrari, U., Seissler, J., Niessen, L., & Lechner, A. Association between depression and diabetes amongst adults in Bangladesh: a hospital based case–control study. Journal of Global Health. 2015;5(2). Islam, S. M. S., Ferrari, U., Seissler, J., Niessen, L., & Lechner, A. Association between depression and diabetes amongst adults in Bangladesh: a hospital based case–control study. Journal of Global Health. 2015;5(2).
13.
go back to reference Islam SMS, Rawal LB, Niessen LW. Prevalence of depression and its associated factors in patients with type 2 diabetes: a cross-sectional study in Dhaka, Bangladesh. Asian J Psychiatry. 2015;17:36–41.CrossRef Islam SMS, Rawal LB, Niessen LW. Prevalence of depression and its associated factors in patients with type 2 diabetes: a cross-sectional study in Dhaka, Bangladesh. Asian J Psychiatry. 2015;17:36–41.CrossRef
14.
go back to reference Safita N, et al. The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls. Health Qual Life Outcomes. 2016;14(1):1–9.CrossRef Safita N, et al. The impact of type 2 diabetes on health related quality of life in Bangladesh: results from a matched study comparing treated cases with non-diabetic controls. Health Qual Life Outcomes. 2016;14(1):1–9.CrossRef
15.
go back to reference Islam SMS, et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Glob Health. 2017;2(1):e000033.CrossRef Islam SMS, et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Glob Health. 2017;2(1):e000033.CrossRef
16.
go back to reference Di Angelantonio E, et al. Association of cardiometabolic multimorbidity with mortality. Jama. 2015;314(1):52–60.PubMedCrossRef Di Angelantonio E, et al. Association of cardiometabolic multimorbidity with mortality. Jama. 2015;314(1):52–60.PubMedCrossRef
17.
go back to reference Matheus, A. S. D. M., Tannus, L. R. M., Cobas, R. A., Palma, C. C. S., Negrato, C. A., & Gomes, M. D. B. Impact of diabetes on cardiovascular disease: an update. International Journal of Hypertension. 2013; 2013. Matheus, A. S. D. M., Tannus, L. R. M., Cobas, R. A., Palma, C. C. S., Negrato, C. A., & Gomes, M. D. B. Impact of diabetes on cardiovascular disease: an update. International Journal of Hypertension. 2013; 2013.
18.
go back to reference Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014. p. 2014. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014. p. 2014.
19.
go back to reference Cha S-A, et al. Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One. 2016;11(10):e0164807.PubMedPubMedCentralCrossRef Cha S-A, et al. Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One. 2016;11(10):e0164807.PubMedPubMedCentralCrossRef
20.
go back to reference Pop-Busui, R., Braffett, B. H., Zinman, B., Martin, C., White, N. H., Herman, W. H., ... & DCCT/EDIC Research Group. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes care. 2017;40(1):94–100. Pop-Busui, R., Braffett, B. H., Zinman, B., Martin, C., White, N. H., Herman, W. H., ... & DCCT/EDIC Research Group. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes care. 2017;40(1):94–100.
21.
go back to reference Alaa AM, et al. Cardiovascular disease risk prediction using automated machine learning: a prospective study of 423,604 UK Biobank participants. PLoS One. 2019;14(5):e0213653.PubMedPubMedCentralCrossRef Alaa AM, et al. Cardiovascular disease risk prediction using automated machine learning: a prospective study of 423,604 UK Biobank participants. PLoS One. 2019;14(5):e0213653.PubMedPubMedCentralCrossRef
22.
go back to reference Abbas H et al. Predicting diabetes in healthy population through machine learning. in 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems (CBMS). 2019. IEEE. Abbas H et al. Predicting diabetes in healthy population through machine learning. in 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems (CBMS). 2019. IEEE.
23.
go back to reference Hossain ME, Uddin S, Khan A. Network analytics and machine learning for predictive risk modelling of cardiovascular disease in patients with type 2 diabetes. Expert Syst Appl. 2021;164:113918.CrossRef Hossain ME, Uddin S, Khan A. Network analytics and machine learning for predictive risk modelling of cardiovascular disease in patients with type 2 diabetes. Expert Syst Appl. 2021;164:113918.CrossRef
24.
go back to reference Garcia-Carretero R, et al. Pulse wave velocity and machine learning to predict cardiovascular outcomes in prediabetic and diabetic populations. J Med Syst. 2020;44(1):1–10.CrossRef Garcia-Carretero R, et al. Pulse wave velocity and machine learning to predict cardiovascular outcomes in prediabetic and diabetic populations. J Med Syst. 2020;44(1):1–10.CrossRef
26.
go back to reference Jelinek HF, Wilding C, Tinely P. An innovative multi-disciplinary diabetes complications screening program in a rural community: a description and preliminary results of the screening. Australian J Prim Health. 2006;12(1):14–20.CrossRef Jelinek HF, Wilding C, Tinely P. An innovative multi-disciplinary diabetes complications screening program in a rural community: a description and preliminary results of the screening. Australian J Prim Health. 2006;12(1):14–20.CrossRef
27.
go back to reference White F, Wang L, Jelinek HF. Management of hypertension in patients with diabetes mellitus. Exp Clin Cardiol. 2010;15(1):5–8.PubMedPubMedCentral White F, Wang L, Jelinek HF. Management of hypertension in patients with diabetes mellitus. Exp Clin Cardiol. 2010;15(1):5–8.PubMedPubMedCentral
28.
go back to reference Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967;54(1–2):167–79.PubMedCrossRef Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967;54(1–2):167–79.PubMedCrossRef
29.
go back to reference Friedman, J. H. Multivariate adaptive regression splines. The Annals of Statistics, 1991;1-67. Friedman, J. H.  Multivariate adaptive regression splines. The Annals of Statistics, 1991;1-67.
30.
go back to reference Hosmer David W, Lemeshow S, Sturdivant Rodney X. Applied logistic regression. New York: Wiley; 2000.CrossRef Hosmer David W, Lemeshow S, Sturdivant Rodney X. Applied logistic regression. New York: Wiley; 2000.CrossRef
31.
go back to reference Zhang W, Goh AT, Zhang Y. Multivariate adaptive regression splines application for multivariate geotechnical problems with big data. Geotech Geol Eng. 2016;34(1):193–204.CrossRef Zhang W, Goh AT, Zhang Y. Multivariate adaptive regression splines application for multivariate geotechnical problems with big data. Geotech Geol Eng. 2016;34(1):193–204.CrossRef
32.
go back to reference Park S, et al. Evaluation of logistic regression and multivariate adaptive regression spline models for groundwater potential mapping using R and GIS. Sustainability. 2017;9(7):1157.CrossRef Park S, et al. Evaluation of logistic regression and multivariate adaptive regression spline models for groundwater potential mapping using R and GIS. Sustainability. 2017;9(7):1157.CrossRef
33.
go back to reference Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Routledge; 2017.CrossRef Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Routledge; 2017.CrossRef
34.
go back to reference Alghamdi M, et al. Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: the Henry ford ExercIse testing (FIT) project. PLoS One. 2017;12(7):e0179805.PubMedPubMedCentralCrossRef Alghamdi M, et al. Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: the Henry ford ExercIse testing (FIT) project. PLoS One. 2017;12(7):e0179805.PubMedPubMedCentralCrossRef
35.
go back to reference Samant P, Agarwal R. Machine learning techniques for medical diagnosis of diabetes using iris images. Comput Methods Prog Biomed. 2018. Samant P, Agarwal R. Machine learning techniques for medical diagnosis of diabetes using iris images. Comput Methods Prog Biomed. 2018.
36.
go back to reference Barakat N, Bradley AP, Barakat MNH. Intelligible support vector machines for diagnosis of diabetes mellitus. IEEE Trans Inf Technol Biomed. 2010;14(4):1114–20.PubMedCrossRef Barakat N, Bradley AP, Barakat MNH. Intelligible support vector machines for diagnosis of diabetes mellitus. IEEE Trans Inf Technol Biomed. 2010;14(4):1114–20.PubMedCrossRef
37.
go back to reference Wu H, et al. Type 2 diabetes mellitus prediction model based on data mining. Inform Med Unlocked. 2018;10:100–7.CrossRef Wu H, et al. Type 2 diabetes mellitus prediction model based on data mining. Inform Med Unlocked. 2018;10:100–7.CrossRef
38.
go back to reference Das R, Turkoglu I, Sengur A. Effective diagnosis of heart disease through neural networks ensembles. Expert Syst Appl. 2009;36(4):7675–80.CrossRef Das R, Turkoglu I, Sengur A. Effective diagnosis of heart disease through neural networks ensembles. Expert Syst Appl. 2009;36(4):7675–80.CrossRef
39.
go back to reference Amiri AM, Armano G. Early diagnosis of heart disease using classification and regression trees. in Neural Networks (IJCNN), The 2013 International Joint Conference on. 2013. IEEE. Amiri AM, Armano G. Early diagnosis of heart disease using classification and regression trees. in Neural Networks (IJCNN), The 2013 International Joint Conference on. 2013. IEEE.
40.
go back to reference Uyar K, İlhan A. Diagnosis of heart disease using genetic algorithm based trained recurrent fuzzy neural networks. Proc Comp Sci. 2017;120:588–93.CrossRef Uyar K, İlhan A. Diagnosis of heart disease using genetic algorithm based trained recurrent fuzzy neural networks. Proc Comp Sci. 2017;120:588–93.CrossRef
41.
go back to reference Masetic Z, Subasi A. Congestive heart failure detection using random forest classifier. Comput Methods Prog Biomed. 2016;130:54–64.CrossRef Masetic Z, Subasi A. Congestive heart failure detection using random forest classifier. Comput Methods Prog Biomed. 2016;130:54–64.CrossRef
42.
go back to reference Yu S-N, Lee M-Y. Conditional mutual information-based feature selection for congestive heart failure recognition using heart rate variability. Comput Methods Prog Biomed. 2012;108(1):299–309.CrossRef Yu S-N, Lee M-Y. Conditional mutual information-based feature selection for congestive heart failure recognition using heart rate variability. Comput Methods Prog Biomed. 2012;108(1):299–309.CrossRef
43.
go back to reference Aktar S, et al. Machine learning approach to predicting COVID-19 disease severity based on clinical blood test data: statistical analysis and model development. JMIR Med Inform. 2021;9(4):e25884.PubMedPubMedCentralCrossRef Aktar S, et al. Machine learning approach to predicting COVID-19 disease severity based on clinical blood test data: statistical analysis and model development. JMIR Med Inform. 2021;9(4):e25884.PubMedPubMedCentralCrossRef
44.
go back to reference Khozeimeh F, et al. Combining a convolutional neural network with autoencoders to predict the survival chance of COVID-19 patients. Sci Rep. 2021;11(1):1–18.CrossRef Khozeimeh F, et al. Combining a convolutional neural network with autoencoders to predict the survival chance of COVID-19 patients. Sci Rep. 2021;11(1):1–18.CrossRef
45.
go back to reference Moni MA, et al. Network-based computational approach to identify delineating common cell pathways influencing type 2 diabetes and diseases of bone and joints. IEEE Access. 2019;8:1486–97.CrossRef Moni MA, et al. Network-based computational approach to identify delineating common cell pathways influencing type 2 diabetes and diseases of bone and joints. IEEE Access. 2019;8:1486–97.CrossRef
46.
go back to reference Rashed-Al-Mahfuz M, et al. Deep convolutional neural networks based ECG beats classification to diagnose cardiovascular conditions. Biomed Eng Lett. 2021;11(2):147–62.PubMedPubMedCentralCrossRef Rashed-Al-Mahfuz M, et al. Deep convolutional neural networks based ECG beats classification to diagnose cardiovascular conditions. Biomed Eng Lett. 2021;11(2):147–62.PubMedPubMedCentralCrossRef
47.
go back to reference Satu M, et al. Short-term prediction of COVID-19 cases using machine learning models. Appl Sci. 2021;11(9):4266.CrossRef Satu M, et al. Short-term prediction of COVID-19 cases using machine learning models. Appl Sci. 2021;11(9):4266.CrossRef
48.
go back to reference Dinh A, et al. A data-driven approach to predicting diabetes and cardiovascular disease with machine learning. BMC Med Inform Dec Making. 2019;19(1):1–15. Dinh A, et al. A data-driven approach to predicting diabetes and cardiovascular disease with machine learning. BMC Med Inform Dec Making. 2019;19(1):1–15.
49.
go back to reference Ji X, Chun SA, Geller J. Predicting comorbid conditions and trajectories using social health records. IEEE Transact Nanobiosci. 2016;15(4):371–9.CrossRef Ji X, Chun SA, Geller J. Predicting comorbid conditions and trajectories using social health records. IEEE Transact Nanobiosci. 2016;15(4):371–9.CrossRef
50.
go back to reference Krishnamurthy M et al. Representing Social Network Patient Data as Evidence-Based Knowledge to Support Decision Making in Disease Progression for Comorbidities. IEEE Access. 2018. Krishnamurthy M et al. Representing Social Network Patient Data as Evidence-Based Knowledge to Support Decision Making in Disease Progression for Comorbidities. IEEE Access. 2018.
51.
go back to reference Boytcheva S, et al. Mining comorbidity patterns using retrospective analysis of big collection of outpatient records. Health Inform Sci Syst. 2017;5(1):3.CrossRef Boytcheva S, et al. Mining comorbidity patterns using retrospective analysis of big collection of outpatient records. Health Inform Sci Syst. 2017;5(1):3.CrossRef
52.
go back to reference He F, et al. Pcid: a novel approach for predicting disease comorbidity by integrating multi-scale data. IEEE/ACM Transact Comput Biol Bioinform (TCBB). 2017;14(3):678–86.CrossRef He F, et al. Pcid: a novel approach for predicting disease comorbidity by integrating multi-scale data. IEEE/ACM Transact Comput Biol Bioinform (TCBB). 2017;14(3):678–86.CrossRef
54.
go back to reference Zheng C-H, et al. Tumor clustering using nonnegative matrix factorization with gene selection. IEEE Trans Inf Technol Biomed. 2009;13(4):599–607.PubMedCrossRef Zheng C-H, et al. Tumor clustering using nonnegative matrix factorization with gene selection. IEEE Trans Inf Technol Biomed. 2009;13(4):599–607.PubMedCrossRef
55.
go back to reference Xia J-F, Zhao X-M, Huang D-S. Predicting protein–protein interactions from protein sequences using meta predictor. Amino Acids. 2010;39(5):1595–9.PubMedCrossRef Xia J-F, Zhao X-M, Huang D-S. Predicting protein–protein interactions from protein sequences using meta predictor. Amino Acids. 2010;39(5):1595–9.PubMedCrossRef
56.
go back to reference Chang C-D, Wang C-C, Jiang BC. Using data mining techniques for multi-diseases prediction modeling of hypertension and hyperlipidemia by common risk factors. Expert Syst Appl. 2011;38(5):5507–13.CrossRef Chang C-D, Wang C-C, Jiang BC. Using data mining techniques for multi-diseases prediction modeling of hypertension and hyperlipidemia by common risk factors. Expert Syst Appl. 2011;38(5):5507–13.CrossRef
58.
go back to reference Association AD. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97.CrossRef Association AD. Standards of medical care in diabetes—2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97.CrossRef
59.
go back to reference Organization WH. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. 2011. Organization WH. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. 2011.
60.
go back to reference Rhee E-J, et al. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study. PLoS One. 2017;12(5):e0176615.PubMedPubMedCentralCrossRef Rhee E-J, et al. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study. PLoS One. 2017;12(5):e0176615.PubMedPubMedCentralCrossRef
62.
go back to reference Bachmann JM et al. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center longitudinal study. Circulation. 2012: CIRCULATIONAHA. 111.065490. Bachmann JM et al. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center longitudinal study. Circulation. 2012: CIRCULATIONAHA. 111.065490.
63.
go back to reference Pandey AK, et al. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand? Atherosclerosis. 2013;228(2):285–94.PubMedCrossRef Pandey AK, et al. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand? Atherosclerosis. 2013;228(2):285–94.PubMedCrossRef
64.
go back to reference Dixit AK, et al. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda hospital. J Diabetes Metabol Disord. 2014;13(1):58.CrossRef Dixit AK, et al. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda hospital. J Diabetes Metabol Disord. 2014;13(1):58.CrossRef
65.
go back to reference Gimeno-Orna J, Faure-Nogueras E, Sancho-Serrano M. Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia. Diabet Med. 2005;22(1):26–31.PubMedCrossRef Gimeno-Orna J, Faure-Nogueras E, Sancho-Serrano M. Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia. Diabet Med. 2005;22(1):26–31.PubMedCrossRef
66.
go back to reference Eeg-Olofsson K, et al. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med. 2010;268(5):471–82.PubMedCrossRef Eeg-Olofsson K, et al. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med. 2010;268(5):471–82.PubMedCrossRef
67.
go back to reference Metelka R, Cibičková L, Gajdová J, Krystyník O. Heart rate variability evaluation in the assessment of cardiac autonomic neuropathy in patients with type 2 diabetes. Cor et Vasa. 2018;60(4):e335–44.CrossRef Metelka R, Cibičková L, Gajdová J, Krystyník O. Heart rate variability evaluation in the assessment of cardiac autonomic neuropathy in patients with type 2 diabetes. Cor et Vasa. 2018;60(4):e335–44.CrossRef
68.
go back to reference Stranieri A, et al. Data-analytically derived flexible HbA1c thresholds for type 2 diabetes mellitus diagnostic. Artif Intell Res. 2015;5(1):111.CrossRef Stranieri A, et al. Data-analytically derived flexible HbA1c thresholds for type 2 diabetes mellitus diagnostic. Artif Intell Res. 2015;5(1):111.CrossRef
69.
go back to reference Sherwani SI et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016. 11: BMI. S38440. Sherwani SI et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016. 11: BMI. S38440.
70.
go back to reference Schmidt MI, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(8):2013–8.PubMedCrossRef Schmidt MI, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(8):2013–8.PubMedCrossRef
71.
go back to reference Barter P, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–10.PubMedCrossRef Barter P, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–10.PubMedCrossRef
73.
go back to reference Vornanen M, et al. Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression. Prev Med. 2016;90:177–83.PubMedCrossRef Vornanen M, et al. Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression. Prev Med. 2016;90:177–83.PubMedCrossRef
74.
75.
go back to reference Islam, S. M. S., & Maddison, R. Digital health approaches for cardiovascular diseases prevention and management: Lessons from preliminary studies. Mhealth. 2021;7. Islam, S. M. S., & Maddison, R. Digital health approaches for cardiovascular diseases prevention and management: Lessons from preliminary studies. Mhealth. 2021;7.
76.
go back to reference Moses JC et al. Application of Smartphone Technologies in Disease Monitoring: A Systematic Review. in Healthcare. 2021. Multidisciplinary Digital Publishing Institute. Moses JC et al. Application of Smartphone Technologies in Disease Monitoring: A Systematic Review. in Healthcare. 2021. Multidisciplinary Digital Publishing Institute.
77.
go back to reference Islam SMS, Chow CK, Redfern J, Kok C, Rådholm K, Stepien S, Hackett ML. Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial. BMJ open. 2019;9(2):e022637. Islam SMS, Chow CK, Redfern J, Kok C, Rådholm K, Stepien S, Hackett ML. Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial. BMJ open. 2019;9(2):e022637.
78.
go back to reference Islam SMS, et al. Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis. Open Heart. 2019;6(2):e001017.CrossRef Islam SMS, et al. Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis. Open Heart. 2019;6(2):e001017.CrossRef
79.
go back to reference Islam SMS, et al. Effects of Mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial. Diabetes Care. 2015;2015(38):112–3.CrossRef Islam SMS, et al. Effects of Mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial. Diabetes Care. 2015;2015(38):112–3.CrossRef
80.
go back to reference Chow CK, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. Jama. 2015;314(12):1255–63.PubMedCrossRef Chow CK, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. Jama. 2015;314(12):1255–63.PubMedCrossRef
Metadata
Title
Machine learning models for prediction of co-occurrence of diabetes and cardiovascular diseases: a retrospective cohort study
Authors
Ahmad Shaker Abdalrada
Jemal Abawajy
Tahsien Al-Quraishi
Sheikh Mohammed Shariful Islam
Publication date
12-01-2022
Publisher
Springer International Publishing
Keyword
Diabetes
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2022
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-021-00968-z

Other articles of this Issue 1/2022

Journal of Diabetes & Metabolic Disorders 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine